Camacho Gomez; Juan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Camacho Gomez; Juan.The latest application filed is for "new n-benzyl-2-phenoxybenzamide derivatives as prostaglandin e2 (pge2) receptors modulators".

Company Profile

0.8.11

Camacho Gomez; Juan - Navarra ES
Camacho Gomez; Juan - Barcelona ES
CAMACHO GOMEZ; Juan - Mataro Barcelona
CAMACHO GOMEZ; Juan - Pamplona Navarra
CAMACHO GOMEZ; Juan - Pamplona-Navarra ES
Camacho Gomez; Juan - Mataro-Barcelona ES
Camacho-Gomez, Juan - Jena DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Androgen receptor and glucocorticoid receptor modulators Grant 11,453,660 - Kurz , et al. September 27, 2	2022-09-27
New N-benzyl-2-phenoxybenzamide Derivatives As Prostaglandin E2 (pge2) Receptors Modulators App 20220117962 - Palomino Laria; Julio Castro ; et al.	2022-04-21
Benzamide derivatives as PPAR-gamma modulators Grant 11,267,808 - Castro Palomino Laria , et al. March 8, 2	2022-03-08
Heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and/or 2(HDAC1-2) Grant 11,241,428 - Castro Palomino Laria , et al. February 8, 2	2022-02-08
New Benzamide Derivatives As Ppar-gamma Modulators App 20210171511 - CASTRO PALOMINO LARIA; Julio ; et al.	2021-06-10
Pyridoquinazoline derivatives useful as protein kinase inhibitors Grant 11,021,479 - Kurz , et al. June 1, 2	2021-06-01
New Analogs As Androgen Receptor And Glucocorticoid Receptor Modulators App 20200325123 - KURZ; Guido ; et al.	2020-10-15
Adenosine A3 receptor modulators Grant 10,744,125 - Castro Palomino Laria , et al. A	2020-08-18
Pyridoquinazoline Derivatives Useful As Protein Kinase Inhibitors App 20200148676 - KURZ; Guido ; et al.	2020-05-14
New Heteroaryl Amide Derivatives As Selective Inhibitors Of Histone Deacetylases 1 And/or 2 (hdac1-2) App 20200138808 - CASTRO PALOMINO LARIA; Julio ; et al.	2020-05-07
Carboxylic Acid Derivatives Of Pyridoquinazolines Useful As Protein Kinase Inhibitors App 20200079773 - KURZ; Guido ; et al.	2020-03-12
Amine salt of (1R, 3S)-3-(5-cyano-4-phenyl-1,3- thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid Grant 10,583,127 - Castro Palomino Laria , et al.	2020-03-10
Amine Salt Of (1r, 3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane Carboxylic Acid App 20200030300 - CASTRO PALOMINO LARIA; Julio ; et al.	2020-01-30
Adenosine A3 Receptor Modulators App 20190374530 - CASTRO PALOMINO LARIA; Julio ; et al.	2019-12-12
Modulators of the adenosine A3 receptors Grant 10,238,637 - Castro-Palomino Laria , et al.	2019-03-26
Modulators Of The Adenosine A3 Receptors App 20180263963 - CASTRO-PALOMINO L RIA; Julio ; et al.	2018-09-20
Pyrimidine derivatives as phosphodiesterase 10 inhibitors (PDE-10) Grant 9,447,095 - Camacho Gomez , et al. September 20, 2	2016-09-20
New Pyrimidine Derivatives As Phosphodiesterase 10 Inhibitors (pde-10) App 20150336953 - CAMACHO GOMEZ; Juan ; et al.	2015-11-26
System and method for analysing active ingredients designed to influence intra-cellular processes App 20040023228 - Bohnert, Georg ; et al.	2004-02-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.